Table 7.
Anthropometric parameters and indices of obesity measurement of the study subjects by body size phenotype
| Metabolically healthy* | Metabolically unhealthy† | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall (n 521) | Normal weight n 145 (27⋅8 %) | Overweight n 149 (28⋅6 %) | Obese n 56 (10⋅7 %) | Normal weight n 11 (2⋅1 %) | Overweight n 42 (8⋅1 %) | Obese n 118, (22⋅6 %) | ||||||||
| Median | IQR | Median | IQR | Median | IQR | Median | IQR | Median | IQR | Median | IQR | Median | IQR | |
| Anthropometric parameters | ||||||||||||||
| BMI (kg/m2) | 27⋅5 | 7⋅8 | 22⋅4 | 2⋅6 | 27⋅1 | 2⋅1 | 33⋅0 | 4⋅1 | 24⋅0 | 1⋅6 | 28⋅2 | 2⋅2 | 34⋅7 | 6⋅7 |
| Waist circumference (cm) | 89⋅0 | 20⋅0 | 74⋅0 | 11⋅0 | 86⋅5 | 11⋅0 | 96⋅0 | 12⋅0 | 82⋅0 | 15⋅0 | 92⋅0 | 10⋅0 | 106⋅0 | 12⋅5 |
| Hip circumference (cm) | 99⋅0 | 16⋅0 | 91⋅0 | 8⋅0 | 98⋅0 | 10⋅0 | 110⋅5 | 13⋅0 | 96⋅0 | 10⋅0 | 101⋅5 | 7⋅0 | 114⋅0 | 16⋅0 |
| Neck circumference (cm) | 35⋅0 | 6⋅0 | 31⋅0 | 2⋅5 | 35⋅6 | 5⋅0 | 36⋅0 | 5⋅5 | 33⋅0 | 8⋅0 | 38⋅0 | 8⋅0 | 40⋅0 | 6⋅0 |
| Mean arm circumference (cm) | 30⋅0 | 5⋅5 | 26⋅0 | 3⋅5 | 29⋅2 | 3⋅0 | 31⋅0 | 2⋅7 | 28⋅0 | 5⋅0 | 30⋅5 | 4⋅0 | 33⋅0 | 4⋅0 |
| Mean thigh circumference (cm) | 52⋅0 | 7⋅5 | 49⋅0 | 4⋅1 | 52⋅0 | 7⋅0 | 56⋅5 | 5⋅0 | 48⋅5 | 9⋅5 | 51⋅3 | 6⋅5 | 58⋅0 | 7⋅5 |
| Average Arm to Height | 0⋅2 | 0⋅0 | 0⋅2 | 0⋅0 | 0⋅2 | 0⋅1 | 0⋅2 | 0⋅0 | 0⋅2 | 0⋅0 | 0⋅2 | 0⋅0 | 0⋅2 | 0⋅0 |
| SBP (mmHg) | 120⋅0 | 10⋅0 | 120⋅0 | 15⋅0 | 120⋅0 | 10⋅0 | 122⋅5 | 8⋅5 | 125⋅0 | 20⋅0 | 125⋅0 | 10⋅0 | 120⋅0 | 15⋅0 |
| DBP (mmHg) | 80⋅0 | 10⋅0 | 80⋅0 | 10⋅0 | 80⋅0 | 10⋅0 | 80⋅0 | 5⋅0 | 80⋅0 | 10⋅0 | 80⋅0 | 5⋅0 | 80⋅0 | 5⋅0 |
| Indices of central obesity measurement | ||||||||||||||
| Visceral Adiposity Index | 1⋅1 | 1⋅1 | 0⋅7 | 0⋅4 | 1⋅0 | 0⋅7 | 0⋅9 | 0⋅4 | 2⋅3 | 1⋅0 | 2⋅1 | 1⋅4 | 2⋅2 | 1⋅5 |
| Waist Height Ratio | 0⋅5 | 0⋅1 | 0⋅5 | 0⋅1 | 0⋅5 | 0⋅1 | 0⋅6 | 0⋅1 | 0⋅5 | 0⋅0 | 0⋅6 | 0⋅0 | 0⋅6 | 0⋅1 |
| Waist Thigh Ratio | 1⋅7 | 0⋅4 | 1⋅5 | 0⋅2 | 1⋅7 | 0⋅3 | 1⋅7 | 0⋅3 | 1⋅6 | 0⋅3 | 1⋅8 | 0⋅3 | 1⋅8 | 0⋅4 |
| Body Adiposity Index | 27⋅9 | 8⋅1 | 25⋅3 | 4⋅3 | 27⋅1 | 6⋅4 | 35⋅0 | 10⋅1 | 29⋅1 | 8⋅7 | 28⋅0 | 6⋅5 | 35⋅6 | 9⋅8 |
| Conicity Index | 1⋅2 | 0⋅1 | 1⋅1 | 0⋅1 | 1⋅2 | 0⋅1 | 1⋅2 | 0⋅1 | 1⋅2 | 0⋅1 | 1⋅3 | 0⋅1 | 1⋅3 | 0⋅1 |
| Abdominal Volume Index | 16⋅0 | 7⋅3 | 11⋅1 | 2⋅8 | 15⋅2 | 3⋅3 | 19⋅1 | 4⋅5 | 13⋅7 | 5⋅0 | 17⋅2 | 3⋅6 | 22⋅8 | 5⋅1 |
| Body Roundness Index | 3⋅9 | 2⋅2 | 2⋅5 | 0⋅9 | 3⋅7 | 0⋅9 | 5⋅1 | 1⋅5 | 3⋅7 | 0⋅9 | 4⋅5 | 0⋅9 | 6⋅2 | 1⋅9 |
| A Body Shape Index | 0⋅1 | 0⋅0 | 0⋅1 | 0⋅0 | 0⋅1 | 0⋅0 | 0⋅1 | 0⋅0 | 0⋅1 | 0⋅0 | 0⋅1 | 0⋅0 | 0⋅1 | 0⋅0 |
| Waist Hip Ratio | 0⋅9 | 0⋅1 | 0⋅8 | 0⋅1 | 0⋅9 | 0⋅1 | 0⋅9 | 0⋅1 | 0⋅9 | 0⋅1 | 0⋅9 | 0⋅1 | 0⋅9 | 0⋅2 |
| Waist Index | 1⋅0 | 0⋅2 | 0⋅9 | 0⋅1 | 1⋅0 | 0⋅1 | 1⋅2 | 0⋅2 | 1⋅0 | 0⋅1 | 1⋅0 | 0⋅2 | 1⋅2 | 0⋅2 |
| Body Roundness Index | 3⋅9 | 2⋅2 | 2⋅5 | 0⋅9 | 3⋅7 | 0⋅9 | 5⋅1 | 1⋅5 | 3⋅7 | 0⋅9 | 4⋅5 | 0⋅9 | 6⋅2 | 1⋅9 |
| A Body Shape Index | 0⋅1 | 0⋅0 | 0⋅1 | 0⋅0 | 0⋅1 | 0⋅0 | 0⋅1 | 0⋅0 | 0⋅1 | 0⋅0 | 0⋅1 | 0⋅0 | 0⋅1 | 0⋅0 |
| Waist Hip Ratio | 0⋅9 | 0⋅1 | 0⋅8 | 0⋅1 | 0⋅9 | 0⋅1 | 0⋅9 | 0⋅1 | 0⋅9 | 0⋅1 | 0⋅9 | 0⋅1 | 0⋅9 | 0⋅2 |
| Waist Index | 1⋅0 | 0⋅2 | 0⋅9 | 0⋅1 | 1⋅0 | 0⋅1 | 1⋅2 | 0⋅2 | 1⋅0 | 0⋅1 | 1⋅0 | 0⋅2 | 1⋅2 | 0⋅2 |
Data are expressed as median + IQR.
Abbreviations: DBP, diastolic blood pressure; SBP, systolic blood pressure.
Metabolically healthy – individuals having ≤1 NCEP-ATPIII criteria (consisting of waist circumference >102 cm in men and >88 cm in women; systolic or diastolic blood pressure ≥130/85 mmHg or on antihypertensive medication; serum triglycerides ≥1⋅69 mmol/l or on lipid-lowering medication; HDL-C <1⋅03 mmol/l in men and <1⋅29 mmol/l in women or on treatment aimed to increase HDL-C; fasting glucose ≥5⋅6 mmol/l or on antihyperglycemic agents.
Metabolically unhealthy – individuals having ≥2 metabolic abnormalities of the NCEP-ATPIII criteria.